LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 99 of 166
Next
>>
>
2451 to 2475 of 4140 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Timepoint	Timepoint Unit	Mean Total Cell Count Before Treatment	Mean Total Cell Count After Treatment	Mean Total Control Cell Count	Mean Relative Cell Count	Mean Normalized Growth Rate Inhibition Value
BT-20	JNK-9L	0.37	uM	LJP6	72	hr	1657	3193	5383	0.5937	0.4715
BT-20	JNK-9L	1.11	uM	LJP6	72	hr	1657	1866	5383	0.3465	0.0714
BT-20	JNK-9L	3.33	uM	LJP6	72	hr	1657	1519	5383	0.2821	-0.0506
BT-20	JNK-9L	10	uM	LJP6	72	hr	1657	1246	5383	0.2316	-0.1549
BT-20	PD0325901	0.04	uM	LJP5	72	hr	1657	5590	5588	1.0004	1.0004
BT-20	PD0325901	0.04	uM	LJP6	72	hr	1657	4960	5383	0.9209	0.9044
BT-20	PD0325901	0.12	uM	LJP5	72	hr	1657	5016	5588	0.8977	0.8803
BT-20	PD0325901	0.12	uM	LJP6	72	hr	1657	4941	5383	0.9177	0.9012
BT-20	PD0325901	0.37	uM	LJP5	72	hr	1657	5192	5588	0.9293	0.9180
BT-20	PD0325901	0.37	uM	LJP6	72	hr	1657	4997	5383	0.9278	0.9129
BT-20	PD0325901	1.11	uM	LJP5	72	hr	1657	4787	5588	0.8570	0.8311
BT-20	PD0325901	1.11	uM	LJP6	72	hr	1657	4352	5383	0.8077	0.7621
BT-20	PD0325901	3.33	uM	LJP5	72	hr	1657	4039	5588	0.7231	0.6622
BT-20	PD0325901	3.33	uM	LJP6	72	hr	1657	3503	5383	0.6501	0.5514
BT-20	PD0325901	10	uM	LJP5	72	hr	1657	3192	5588	0.5715	0.4532
BT-20	PD0325901	10	uM	LJP6	72	hr	1657	3157	5383	0.5864	0.4604
BT-20	Geldanamycin	0.04	uM	LJP5	72	hr	1657	2646	5588	0.4735	0.3043
BT-20	Geldanamycin	0.04	uM	LJP6	72	hr	1657	2703	5383	0.5021	0.3329
BT-20	Geldanamycin	0.12	uM	LJP5	72	hr	1657	1971	5588	0.3529	0.1035
BT-20	Geldanamycin	0.12	uM	LJP6	72	hr	1657	1888	5383	0.3511	0.0800
BT-20	Geldanamycin	0.37	uM	LJP5	72	hr	1657	1776	5588	0.3179	0.0400
BT-20	Geldanamycin	0.37	uM	LJP6	72	hr	1657	1855	5383	0.3447	0.0682
BT-20	Geldanamycin	1.11	uM	LJP5	72	hr	1657	1916	5588	0.3429	0.0861
BT-20	Geldanamycin	1.11	uM	LJP6	72	hr	1657	1894	5383	0.3522	0.0819
BT-20	Geldanamycin	3.33	uM	LJP5	72	hr	1657	1735	5588	0.3106	0.0264

|<
<<
Previous
Page 99 of 166
Next
>>
>
2451 to 2475 of 4140 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)